nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HTR6—Alzheimer's disease	0.214	0.514	CbGaD
Doxepin—SLC6A4—Alzheimer's disease	0.082	0.197	CbGaD
Doxepin—HTR2A—Donepezil—Alzheimer's disease	0.0721	0.243	CbGbCtD
Doxepin—HTR2A—Alzheimer's disease	0.063	0.151	CbGaD
Doxepin—CYP2D6—Alzheimer's disease	0.0576	0.138	CbGaD
Doxepin—DRD2—Memantine—Alzheimer's disease	0.0576	0.194	CbGbCtD
Doxepin—CYP2D6—Rivastigmine—Alzheimer's disease	0.03	0.101	CbGbCtD
Doxepin—CYP2C19—Memantine—Alzheimer's disease	0.0273	0.0921	CbGbCtD
Doxepin—CYP2C9—Donepezil—Alzheimer's disease	0.0262	0.0883	CbGbCtD
Doxepin—CYP2D6—Donepezil—Alzheimer's disease	0.024	0.0808	CbGbCtD
Doxepin—CYP3A4—Rivastigmine—Alzheimer's disease	0.0191	0.0643	CbGbCtD
Doxepin—CYP2D6—Galantamine—Alzheimer's disease	0.0154	0.0521	CbGbCtD
Doxepin—CYP3A4—Donepezil—Alzheimer's disease	0.0152	0.0514	CbGbCtD
Doxepin—CYP3A4—Galantamine—Alzheimer's disease	0.00982	0.0331	CbGbCtD
Doxepin—HTR2C—choroid plexus—Alzheimer's disease	0.00633	0.113	CbGeAlD
Doxepin—SLC6A2—locus ceruleus—Alzheimer's disease	0.00327	0.0582	CbGeAlD
Doxepin—HTR2A—choroid plexus—Alzheimer's disease	0.00318	0.0566	CbGeAlD
Doxepin—HTR2A—locus ceruleus—Alzheimer's disease	0.00196	0.035	CbGeAlD
Doxepin—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00186	0.0331	CbGeAlD
Doxepin—HTR2A—cerebellar cortex—Alzheimer's disease	0.0016	0.0285	CbGeAlD
Doxepin—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00156	0.0278	CbGeAlD
Doxepin—DRD2—telencephalic ventricle—Alzheimer's disease	0.00141	0.0252	CbGeAlD
Doxepin—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000931	0.0166	CbGeAlD
Doxepin—HTR6—forebrain—Alzheimer's disease	0.000839	0.0149	CbGeAlD
Doxepin—HTR6—telencephalon—Alzheimer's disease	0.000771	0.0137	CbGeAlD
Doxepin—Olopatadine—S100B—Alzheimer's disease	0.000679	0.176	CrCbGaD
Doxepin—ADRA1D—forebrain—Alzheimer's disease	0.000655	0.0117	CbGeAlD
Doxepin—ADRA1D—telencephalon—Alzheimer's disease	0.000602	0.0107	CbGeAlD
Doxepin—CHRM4—nervous system—Alzheimer's disease	0.000509	0.00907	CbGeAlD
Doxepin—CHRM2—forebrain—Alzheimer's disease	0.000503	0.00896	CbGeAlD
Doxepin—CHRM4—central nervous system—Alzheimer's disease	0.00049	0.00873	CbGeAlD
Doxepin—HTR2C—forebrain—Alzheimer's disease	0.000485	0.00864	CbGeAlD
Doxepin—CHRM2—telencephalon—Alzheimer's disease	0.000462	0.00824	CbGeAlD
Doxepin—HTR2A—blood vessel—Alzheimer's disease	0.000461	0.00821	CbGeAlD
Doxepin—SLC6A4—forebrain—Alzheimer's disease	0.000459	0.00819	CbGeAlD
Doxepin—CHRM1—forebrain—Alzheimer's disease	0.000458	0.00816	CbGeAlD
Doxepin—HTR6—nervous system—Alzheimer's disease	0.000455	0.00811	CbGeAlD
Doxepin—HTR2B—forebrain—Alzheimer's disease	0.000455	0.00811	CbGeAlD
Doxepin—HTR2C—telencephalon—Alzheimer's disease	0.000446	0.00794	CbGeAlD
Doxepin—HTR6—central nervous system—Alzheimer's disease	0.000438	0.00781	CbGeAlD
Doxepin—SLC6A4—telencephalon—Alzheimer's disease	0.000422	0.00753	CbGeAlD
Doxepin—CHRM1—telencephalon—Alzheimer's disease	0.000421	0.0075	CbGeAlD
Doxepin—HTR2B—telencephalon—Alzheimer's disease	0.000419	0.00746	CbGeAlD
Doxepin—HRH2—nervous system—Alzheimer's disease	0.000416	0.00742	CbGeAlD
Doxepin—CHRM3—forebrain—Alzheimer's disease	0.00041	0.0073	CbGeAlD
Doxepin—HTR1A—forebrain—Alzheimer's disease	0.000408	0.00727	CbGeAlD
Doxepin—SLC6A2—forebrain—Alzheimer's disease	0.000404	0.00721	CbGeAlD
Doxepin—HRH2—central nervous system—Alzheimer's disease	0.000401	0.00714	CbGeAlD
Doxepin—CHRM5—nervous system—Alzheimer's disease	0.000398	0.00709	CbGeAlD
Doxepin—Dimetacrine—ACHE—Alzheimer's disease	0.000393	0.102	CrCbGaD
Doxepin—CHRM4—brain—Alzheimer's disease	0.000389	0.00693	CbGeAlD
Doxepin—CHRM5—central nervous system—Alzheimer's disease	0.000383	0.00682	CbGeAlD
Doxepin—CHRM3—telencephalon—Alzheimer's disease	0.000377	0.00671	CbGeAlD
Doxepin—ADRA1A—forebrain—Alzheimer's disease	0.000376	0.0067	CbGeAlD
Doxepin—HTR1A—telencephalon—Alzheimer's disease	0.000375	0.00668	CbGeAlD
Doxepin—SLC6A2—telencephalon—Alzheimer's disease	0.000372	0.00663	CbGeAlD
Doxepin—DRD2—forebrain—Alzheimer's disease	0.000369	0.00657	CbGeAlD
Doxepin—ADRA1B—nervous system—Alzheimer's disease	0.000363	0.00647	CbGeAlD
Doxepin—KCNH2—forebrain—Alzheimer's disease	0.000363	0.00647	CbGeAlD
Doxepin—ADRA1D—nervous system—Alzheimer's disease	0.000355	0.00633	CbGeAlD
Doxepin—ADRA1B—central nervous system—Alzheimer's disease	0.00035	0.00623	CbGeAlD
Doxepin—HTR6—brain—Alzheimer's disease	0.000348	0.0062	CbGeAlD
Doxepin—ADRA1A—telencephalon—Alzheimer's disease	0.000346	0.00616	CbGeAlD
Doxepin—ADRA1D—central nervous system—Alzheimer's disease	0.000342	0.0061	CbGeAlD
Doxepin—DRD2—telencephalon—Alzheimer's disease	0.000339	0.00604	CbGeAlD
Doxepin—KCNH2—telencephalon—Alzheimer's disease	0.000334	0.00595	CbGeAlD
Doxepin—ADRA2C—telencephalon—Alzheimer's disease	0.000329	0.00587	CbGeAlD
Doxepin—HRH2—brain—Alzheimer's disease	0.000318	0.00567	CbGeAlD
Doxepin—CHRM5—brain—Alzheimer's disease	0.000304	0.00542	CbGeAlD
Doxepin—ABCB1—blood vessel—Alzheimer's disease	0.000302	0.00538	CbGeAlD
Doxepin—ORM1—nervous system—Alzheimer's disease	0.000293	0.00522	CbGeAlD
Doxepin—HRH1—forebrain—Alzheimer's disease	0.000291	0.00519	CbGeAlD
Doxepin—ADRA2A—forebrain—Alzheimer's disease	0.000286	0.00509	CbGeAlD
Doxepin—ORM1—central nervous system—Alzheimer's disease	0.000282	0.00502	CbGeAlD
Doxepin—ADRA1B—brain—Alzheimer's disease	0.000278	0.00495	CbGeAlD
Doxepin—HTR2A—embryo—Alzheimer's disease	0.000275	0.0049	CbGeAlD
Doxepin—CHRM2—nervous system—Alzheimer's disease	0.000273	0.00486	CbGeAlD
Doxepin—ADRA1D—brain—Alzheimer's disease	0.000272	0.00484	CbGeAlD
Doxepin—HRH1—telencephalon—Alzheimer's disease	0.000268	0.00477	CbGeAlD
Doxepin—HTR2C—nervous system—Alzheimer's disease	0.000263	0.00469	CbGeAlD
Doxepin—ADRA2A—telencephalon—Alzheimer's disease	0.000263	0.00468	CbGeAlD
Doxepin—CHRM2—central nervous system—Alzheimer's disease	0.000263	0.00468	CbGeAlD
Doxepin—HTR2C—central nervous system—Alzheimer's disease	0.000253	0.00451	CbGeAlD
Doxepin—SLC6A4—nervous system—Alzheimer's disease	0.000249	0.00444	CbGeAlD
Doxepin—CHRM1—nervous system—Alzheimer's disease	0.000248	0.00443	CbGeAlD
Doxepin—HTR2B—nervous system—Alzheimer's disease	0.000247	0.0044	CbGeAlD
Doxepin—HTR2A—forebrain—Alzheimer's disease	0.000243	0.00433	CbGeAlD
Doxepin—Amitriptyline—NTRK2—Alzheimer's disease	0.000243	0.0629	CrCbGaD
Doxepin—SLC6A4—central nervous system—Alzheimer's disease	0.00024	0.00428	CbGeAlD
Doxepin—CHRM1—central nervous system—Alzheimer's disease	0.000239	0.00426	CbGeAlD
Doxepin—HTR2B—central nervous system—Alzheimer's disease	0.000238	0.00424	CbGeAlD
Doxepin—HTR2A—telencephalon—Alzheimer's disease	0.000224	0.00398	CbGeAlD
Doxepin—CHRM3—nervous system—Alzheimer's disease	0.000222	0.00396	CbGeAlD
Doxepin—CYP2D6—forebrain—Alzheimer's disease	0.000221	0.00395	CbGeAlD
Doxepin—HTR1A—nervous system—Alzheimer's disease	0.000221	0.00395	CbGeAlD
Doxepin—SLC6A2—nervous system—Alzheimer's disease	0.00022	0.00391	CbGeAlD
Doxepin—CHRM3—central nervous system—Alzheimer's disease	0.000214	0.00381	CbGeAlD
Doxepin—HTR1A—central nervous system—Alzheimer's disease	0.000213	0.0038	CbGeAlD
Doxepin—SLC6A2—central nervous system—Alzheimer's disease	0.000211	0.00377	CbGeAlD
Doxepin—CHRM2—brain—Alzheimer's disease	0.000209	0.00372	CbGeAlD
Doxepin—HTR1A—cerebellum—Alzheimer's disease	0.000208	0.00371	CbGeAlD
Doxepin—Thiothixene—HTR6—Alzheimer's disease	0.000204	0.0529	CrCbGaD
Doxepin—ADRA1A—nervous system—Alzheimer's disease	0.000204	0.00364	CbGeAlD
Doxepin—CYP2D6—telencephalon—Alzheimer's disease	0.000204	0.00363	CbGeAlD
Doxepin—HTR2C—brain—Alzheimer's disease	0.000201	0.00358	CbGeAlD
Doxepin—DRD2—nervous system—Alzheimer's disease	0.0002	0.00357	CbGeAlD
Doxepin—KCNH2—nervous system—Alzheimer's disease	0.000197	0.00351	CbGeAlD
Doxepin—ADRA1A—central nervous system—Alzheimer's disease	0.000197	0.0035	CbGeAlD
Doxepin—ADRA2C—nervous system—Alzheimer's disease	0.000195	0.00347	CbGeAlD
Doxepin—DRD2—central nervous system—Alzheimer's disease	0.000193	0.00343	CbGeAlD
Doxepin—ADRA1A—cerebellum—Alzheimer's disease	0.000192	0.00342	CbGeAlD
Doxepin—SLC6A4—brain—Alzheimer's disease	0.000191	0.0034	CbGeAlD
Doxepin—CHRM1—brain—Alzheimer's disease	0.00019	0.00338	CbGeAlD
Doxepin—KCNH2—central nervous system—Alzheimer's disease	0.00019	0.00338	CbGeAlD
Doxepin—HTR2B—brain—Alzheimer's disease	0.000189	0.00337	CbGeAlD
Doxepin—DRD2—cerebellum—Alzheimer's disease	0.000188	0.00336	CbGeAlD
Doxepin—ADRA2C—central nervous system—Alzheimer's disease	0.000187	0.00334	CbGeAlD
Doxepin—KCNH2—cerebellum—Alzheimer's disease	0.000186	0.00331	CbGeAlD
Doxepin—ADRA2C—cerebellum—Alzheimer's disease	0.000183	0.00326	CbGeAlD
Doxepin—Oedema peripheral—Memantine—Alzheimer's disease	0.000181	0.00119	CcSEcCtD
Doxepin—Arrhythmia—Donepezil—Alzheimer's disease	0.000181	0.00118	CcSEcCtD
Doxepin—Connective tissue disorder—Memantine—Alzheimer's disease	0.000181	0.00118	CcSEcCtD
Doxepin—Skin disorder—Galantamine—Alzheimer's disease	0.00018	0.00118	CcSEcCtD
Doxepin—Urethral disorder—Memantine—Alzheimer's disease	0.00018	0.00118	CcSEcCtD
Doxepin—ABCB1—embryo—Alzheimer's disease	0.00018	0.00321	CbGeAlD
Doxepin—Hepatitis—Rivastigmine—Alzheimer's disease	0.00018	0.00118	CcSEcCtD
Doxepin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000179	0.00118	CcSEcCtD
Doxepin—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000179	0.00117	CcSEcCtD
Doxepin—Hallucination—Rivastigmine—Alzheimer's disease	0.000179	0.00117	CcSEcCtD
Doxepin—Alopecia—Donepezil—Alzheimer's disease	0.000179	0.00117	CcSEcCtD
Doxepin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000178	0.00117	CcSEcCtD
Doxepin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000178	0.00116	CcSEcCtD
Doxepin—Mental disorder—Donepezil—Alzheimer's disease	0.000177	0.00116	CcSEcCtD
Doxepin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000177	0.00116	CcSEcCtD
Doxepin—Anorexia—Galantamine—Alzheimer's disease	0.000177	0.00116	CcSEcCtD
Doxepin—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000177	0.00116	CcSEcCtD
Doxepin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000176	0.00115	CcSEcCtD
Doxepin—Malnutrition—Donepezil—Alzheimer's disease	0.000176	0.00115	CcSEcCtD
Doxepin—Erythema—Donepezil—Alzheimer's disease	0.000176	0.00115	CcSEcCtD
Doxepin—Flatulence—Donepezil—Alzheimer's disease	0.000174	0.00114	CcSEcCtD
Doxepin—Hypotension—Galantamine—Alzheimer's disease	0.000173	0.00114	CcSEcCtD
Doxepin—Tension—Donepezil—Alzheimer's disease	0.000173	0.00113	CcSEcCtD
Doxepin—Dysgeusia—Donepezil—Alzheimer's disease	0.000173	0.00113	CcSEcCtD
Doxepin—Eye disorder—Memantine—Alzheimer's disease	0.000172	0.00113	CcSEcCtD
Doxepin—Tinnitus—Memantine—Alzheimer's disease	0.000171	0.00112	CcSEcCtD
Doxepin—Nervousness—Donepezil—Alzheimer's disease	0.000171	0.00112	CcSEcCtD
Doxepin—Flushing—Memantine—Alzheimer's disease	0.000171	0.00112	CcSEcCtD
Doxepin—Cardiac disorder—Memantine—Alzheimer's disease	0.000171	0.00112	CcSEcCtD
Doxepin—Back pain—Donepezil—Alzheimer's disease	0.00017	0.00112	CcSEcCtD
Doxepin—CHRM3—brain—Alzheimer's disease	0.00017	0.00303	CbGeAlD
Doxepin—Muscle spasms—Donepezil—Alzheimer's disease	0.000169	0.00111	CcSEcCtD
Doxepin—HTR1A—brain—Alzheimer's disease	0.000169	0.00302	CbGeAlD
Doxepin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000169	0.00111	CcSEcCtD
Doxepin—Eye disorder—Rivastigmine—Alzheimer's disease	0.000168	0.0011	CcSEcCtD
Doxepin—Insomnia—Galantamine—Alzheimer's disease	0.000168	0.0011	CcSEcCtD
Doxepin—SLC6A2—brain—Alzheimer's disease	0.000168	0.00299	CbGeAlD
Doxepin—Tinnitus—Rivastigmine—Alzheimer's disease	0.000168	0.0011	CcSEcCtD
Doxepin—Flushing—Rivastigmine—Alzheimer's disease	0.000167	0.00109	CcSEcCtD
Doxepin—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000167	0.00109	CcSEcCtD
Doxepin—Angiopathy—Memantine—Alzheimer's disease	0.000167	0.00109	CcSEcCtD
Doxepin—Paraesthesia—Galantamine—Alzheimer's disease	0.000167	0.00109	CcSEcCtD
Doxepin—Vision blurred—Donepezil—Alzheimer's disease	0.000166	0.00109	CcSEcCtD
Doxepin—Immune system disorder—Memantine—Alzheimer's disease	0.000166	0.00109	CcSEcCtD
Doxepin—Mediastinal disorder—Memantine—Alzheimer's disease	0.000166	0.00108	CcSEcCtD
Doxepin—Tremor—Donepezil—Alzheimer's disease	0.000165	0.00108	CcSEcCtD
Doxepin—Somnolence—Galantamine—Alzheimer's disease	0.000165	0.00108	CcSEcCtD
Doxepin—Chills—Memantine—Alzheimer's disease	0.000165	0.00108	CcSEcCtD
Doxepin—Arrhythmia—Memantine—Alzheimer's disease	0.000164	0.00108	CcSEcCtD
Doxepin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000164	0.00107	CcSEcCtD
Doxepin—Dyspepsia—Galantamine—Alzheimer's disease	0.000163	0.00107	CcSEcCtD
Doxepin—Angiopathy—Rivastigmine—Alzheimer's disease	0.000163	0.00107	CcSEcCtD
Doxepin—Anaemia—Donepezil—Alzheimer's disease	0.000163	0.00107	CcSEcCtD
Doxepin—Alopecia—Memantine—Alzheimer's disease	0.000162	0.00106	CcSEcCtD
Doxepin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000162	0.00106	CcSEcCtD
Doxepin—Agitation—Donepezil—Alzheimer's disease	0.000162	0.00106	CcSEcCtD
Doxepin—Clomipramine—HTR6—Alzheimer's disease	0.000161	0.0418	CrCbGaD
Doxepin—Chills—Rivastigmine—Alzheimer's disease	0.000161	0.00106	CcSEcCtD
Doxepin—Decreased appetite—Galantamine—Alzheimer's disease	0.000161	0.00106	CcSEcCtD
Doxepin—Mental disorder—Memantine—Alzheimer's disease	0.000161	0.00105	CcSEcCtD
Doxepin—Chlorprothixene—HTR6—Alzheimer's disease	0.000161	0.0416	CrCbGaD
Doxepin—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000161	0.00105	CcSEcCtD
Doxepin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00016	0.00105	CcSEcCtD
Doxepin—Malnutrition—Memantine—Alzheimer's disease	0.00016	0.00105	CcSEcCtD
Doxepin—Fatigue—Galantamine—Alzheimer's disease	0.00016	0.00105	CcSEcCtD
Doxepin—ABCB1—forebrain—Alzheimer's disease	0.000159	0.00284	CbGeAlD
Doxepin—Malaise—Donepezil—Alzheimer's disease	0.000159	0.00104	CcSEcCtD
Doxepin—Alopecia—Rivastigmine—Alzheimer's disease	0.000159	0.00104	CcSEcCtD
Doxepin—Constipation—Galantamine—Alzheimer's disease	0.000159	0.00104	CcSEcCtD
Doxepin—Promethazine—CALM1—Alzheimer's disease	0.000158	0.041	CrCbGaD
Doxepin—Vertigo—Donepezil—Alzheimer's disease	0.000158	0.00104	CcSEcCtD
Doxepin—Syncope—Donepezil—Alzheimer's disease	0.000158	0.00104	CcSEcCtD
Doxepin—HRH1—nervous system—Alzheimer's disease	0.000158	0.00282	CbGeAlD
Doxepin—Nortriptyline—HTR6—Alzheimer's disease	0.000158	0.0408	CrCbGaD
Doxepin—Flatulence—Memantine—Alzheimer's disease	0.000158	0.00103	CcSEcCtD
Doxepin—Mental disorder—Rivastigmine—Alzheimer's disease	0.000158	0.00103	CcSEcCtD
Doxepin—Tension—Memantine—Alzheimer's disease	0.000157	0.00103	CcSEcCtD
Doxepin—Dysgeusia—Memantine—Alzheimer's disease	0.000157	0.00103	CcSEcCtD
Doxepin—Erythema—Rivastigmine—Alzheimer's disease	0.000157	0.00103	CcSEcCtD
Doxepin—Malnutrition—Rivastigmine—Alzheimer's disease	0.000157	0.00103	CcSEcCtD
Doxepin—ADRA1A—brain—Alzheimer's disease	0.000156	0.00278	CbGeAlD
Doxepin—Nervousness—Memantine—Alzheimer's disease	0.000155	0.00102	CcSEcCtD
Doxepin—ADRA2A—nervous system—Alzheimer's disease	0.000155	0.00277	CbGeAlD
Doxepin—Loss of consciousness—Donepezil—Alzheimer's disease	0.000155	0.00101	CcSEcCtD
Doxepin—Back pain—Memantine—Alzheimer's disease	0.000155	0.00101	CcSEcCtD
Doxepin—Flatulence—Rivastigmine—Alzheimer's disease	0.000154	0.00101	CcSEcCtD
Doxepin—Cough—Donepezil—Alzheimer's disease	0.000154	0.00101	CcSEcCtD
Doxepin—Tension—Rivastigmine—Alzheimer's disease	0.000154	0.00101	CcSEcCtD
Doxepin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000153	0.001	CcSEcCtD
Doxepin—Feeling abnormal—Galantamine—Alzheimer's disease	0.000153	0.001	CcSEcCtD
Doxepin—DRD2—brain—Alzheimer's disease	0.000153	0.00273	CbGeAlD
Doxepin—Convulsion—Donepezil—Alzheimer's disease	0.000153	0.001	CcSEcCtD
Doxepin—Hypertension—Donepezil—Alzheimer's disease	0.000152	0.000996	CcSEcCtD
Doxepin—HRH1—central nervous system—Alzheimer's disease	0.000152	0.00271	CbGeAlD
Doxepin—Nervousness—Rivastigmine—Alzheimer's disease	0.000152	0.000996	CcSEcCtD
Doxepin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000152	0.000994	CcSEcCtD
Doxepin—Back pain—Rivastigmine—Alzheimer's disease	0.000151	0.000992	CcSEcCtD
Doxepin—Vision blurred—Memantine—Alzheimer's disease	0.000151	0.000988	CcSEcCtD
Doxepin—KCNH2—brain—Alzheimer's disease	0.000151	0.00269	CbGeAlD
Doxepin—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000151	0.000986	CcSEcCtD
Doxepin—Chest pain—Donepezil—Alzheimer's disease	0.00015	0.000983	CcSEcCtD
Doxepin—Arthralgia—Donepezil—Alzheimer's disease	0.00015	0.000983	CcSEcCtD
Doxepin—Myalgia—Donepezil—Alzheimer's disease	0.00015	0.000983	CcSEcCtD
Doxepin—Tremor—Memantine—Alzheimer's disease	0.00015	0.000982	CcSEcCtD
Doxepin—Anxiety—Donepezil—Alzheimer's disease	0.00015	0.000979	CcSEcCtD
Doxepin—ADRA2A—central nervous system—Alzheimer's disease	0.000149	0.00266	CbGeAlD
Doxepin—ADRA2C—brain—Alzheimer's disease	0.000149	0.00265	CbGeAlD
Doxepin—Ill-defined disorder—Memantine—Alzheimer's disease	0.000148	0.000972	CcSEcCtD
Doxepin—Discomfort—Donepezil—Alzheimer's disease	0.000148	0.000971	CcSEcCtD
Doxepin—Anaemia—Memantine—Alzheimer's disease	0.000148	0.000969	CcSEcCtD
Doxepin—Vision blurred—Rivastigmine—Alzheimer's disease	0.000148	0.000966	CcSEcCtD
Doxepin—Agitation—Memantine—Alzheimer's disease	0.000147	0.000963	CcSEcCtD
Doxepin—Dry mouth—Donepezil—Alzheimer's disease	0.000147	0.000961	CcSEcCtD
Doxepin—Body temperature increased—Galantamine—Alzheimer's disease	0.000147	0.000961	CcSEcCtD
Doxepin—Abdominal pain—Galantamine—Alzheimer's disease	0.000147	0.000961	CcSEcCtD
Doxepin—Tremor—Rivastigmine—Alzheimer's disease	0.000147	0.000961	CcSEcCtD
Doxepin—ABCB1—telencephalon—Alzheimer's disease	0.000146	0.00261	CbGeAlD
Doxepin—ADRA2A—cerebellum—Alzheimer's disease	0.000146	0.0026	CbGeAlD
Doxepin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000145	0.000951	CcSEcCtD
Doxepin—Confusional state—Donepezil—Alzheimer's disease	0.000145	0.00095	CcSEcCtD
Doxepin—Anaemia—Rivastigmine—Alzheimer's disease	0.000145	0.000948	CcSEcCtD
Doxepin—Malaise—Memantine—Alzheimer's disease	0.000144	0.000945	CcSEcCtD
Doxepin—Agitation—Rivastigmine—Alzheimer's disease	0.000144	0.000942	CcSEcCtD
Doxepin—Oedema—Donepezil—Alzheimer's disease	0.000144	0.000942	CcSEcCtD
Doxepin—Vertigo—Memantine—Alzheimer's disease	0.000144	0.000942	CcSEcCtD
Doxepin—Syncope—Memantine—Alzheimer's disease	0.000144	0.00094	CcSEcCtD
Doxepin—Leukopenia—Memantine—Alzheimer's disease	0.000143	0.000938	CcSEcCtD
Doxepin—Infection—Donepezil—Alzheimer's disease	0.000143	0.000936	CcSEcCtD
Doxepin—Shock—Donepezil—Alzheimer's disease	0.000142	0.000927	CcSEcCtD
Doxepin—Palpitations—Memantine—Alzheimer's disease	0.000141	0.000926	CcSEcCtD
Doxepin—Malaise—Rivastigmine—Alzheimer's disease	0.000141	0.000925	CcSEcCtD
Doxepin—Nervous system disorder—Donepezil—Alzheimer's disease	0.000141	0.000924	CcSEcCtD
Doxepin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000141	0.000922	CcSEcCtD
Doxepin—Vertigo—Rivastigmine—Alzheimer's disease	0.000141	0.000921	CcSEcCtD
Doxepin—Loss of consciousness—Memantine—Alzheimer's disease	0.000141	0.000921	CcSEcCtD
Doxepin—Syncope—Rivastigmine—Alzheimer's disease	0.00014	0.000919	CcSEcCtD
Doxepin—Cough—Memantine—Alzheimer's disease	0.00014	0.000914	CcSEcCtD
Doxepin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000139	0.000911	CcSEcCtD
Doxepin—Convulsion—Memantine—Alzheimer's disease	0.000139	0.000908	CcSEcCtD
Doxepin—Palpitations—Rivastigmine—Alzheimer's disease	0.000138	0.000906	CcSEcCtD
Doxepin—Hypertension—Memantine—Alzheimer's disease	0.000138	0.000905	CcSEcCtD
Doxepin—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000138	0.000901	CcSEcCtD
Doxepin—Anorexia—Donepezil—Alzheimer's disease	0.000137	0.000898	CcSEcCtD
Doxepin—Hypersensitivity—Galantamine—Alzheimer's disease	0.000137	0.000896	CcSEcCtD
Doxepin—Cough—Rivastigmine—Alzheimer's disease	0.000137	0.000895	CcSEcCtD
Doxepin—Myalgia—Memantine—Alzheimer's disease	0.000136	0.000892	CcSEcCtD
Doxepin—Arthralgia—Memantine—Alzheimer's disease	0.000136	0.000892	CcSEcCtD
Doxepin—Chest pain—Memantine—Alzheimer's disease	0.000136	0.000892	CcSEcCtD
Doxepin—Anxiety—Memantine—Alzheimer's disease	0.000136	0.000889	CcSEcCtD
Doxepin—Convulsion—Rivastigmine—Alzheimer's disease	0.000136	0.000888	CcSEcCtD
Doxepin—Hypertension—Rivastigmine—Alzheimer's disease	0.000135	0.000885	CcSEcCtD
Doxepin—Discomfort—Memantine—Alzheimer's disease	0.000135	0.000882	CcSEcCtD
Doxepin—Hypotension—Donepezil—Alzheimer's disease	0.000134	0.00088	CcSEcCtD
Doxepin—Arthralgia—Rivastigmine—Alzheimer's disease	0.000133	0.000873	CcSEcCtD
Doxepin—Chest pain—Rivastigmine—Alzheimer's disease	0.000133	0.000873	CcSEcCtD
Doxepin—Myalgia—Rivastigmine—Alzheimer's disease	0.000133	0.000873	CcSEcCtD
Doxepin—Dry mouth—Memantine—Alzheimer's disease	0.000133	0.000873	CcSEcCtD
Doxepin—Asthenia—Galantamine—Alzheimer's disease	0.000133	0.000872	CcSEcCtD
Doxepin—Anxiety—Rivastigmine—Alzheimer's disease	0.000133	0.00087	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000132	0.000867	CcSEcCtD
Doxepin—HTR2A—nervous system—Alzheimer's disease	0.000132	0.00235	CbGeAlD
Doxepin—Confusional state—Memantine—Alzheimer's disease	0.000132	0.000862	CcSEcCtD
Doxepin—Discomfort—Rivastigmine—Alzheimer's disease	0.000132	0.000862	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000131	0.000858	CcSEcCtD
Doxepin—Oedema—Memantine—Alzheimer's disease	0.000131	0.000855	CcSEcCtD
Doxepin—Dry mouth—Rivastigmine—Alzheimer's disease	0.00013	0.000854	CcSEcCtD
Doxepin—Insomnia—Donepezil—Alzheimer's disease	0.00013	0.000852	CcSEcCtD
Doxepin—Infection—Memantine—Alzheimer's disease	0.00013	0.00085	CcSEcCtD
Doxepin—Paraesthesia—Donepezil—Alzheimer's disease	0.000129	0.000846	CcSEcCtD
Doxepin—Confusional state—Rivastigmine—Alzheimer's disease	0.000129	0.000844	CcSEcCtD
Doxepin—Shock—Memantine—Alzheimer's disease	0.000128	0.000841	CcSEcCtD
Doxepin—Dyspnoea—Donepezil—Alzheimer's disease	0.000128	0.00084	CcSEcCtD
Doxepin—Nervous system disorder—Memantine—Alzheimer's disease	0.000128	0.000839	CcSEcCtD
Doxepin—Somnolence—Donepezil—Alzheimer's disease	0.000128	0.000837	CcSEcCtD
Doxepin—Thrombocytopenia—Memantine—Alzheimer's disease	0.000128	0.000837	CcSEcCtD
Doxepin—Oedema—Rivastigmine—Alzheimer's disease	0.000128	0.000837	CcSEcCtD
Doxepin—Tachycardia—Memantine—Alzheimer's disease	0.000127	0.000835	CcSEcCtD
Doxepin—HTR2A—central nervous system—Alzheimer's disease	0.000127	0.00226	CbGeAlD
Doxepin—Diarrhoea—Galantamine—Alzheimer's disease	0.000127	0.000832	CcSEcCtD
Doxepin—Infection—Rivastigmine—Alzheimer's disease	0.000127	0.000831	CcSEcCtD
Doxepin—Skin disorder—Memantine—Alzheimer's disease	0.000127	0.000831	CcSEcCtD
Doxepin—Dyspepsia—Donepezil—Alzheimer's disease	0.000127	0.000829	CcSEcCtD
Doxepin—Hyperhidrosis—Memantine—Alzheimer's disease	0.000126	0.000827	CcSEcCtD
Doxepin—Shock—Rivastigmine—Alzheimer's disease	0.000126	0.000823	CcSEcCtD
Doxepin—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000125	0.000821	CcSEcCtD
Doxepin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000125	0.000819	CcSEcCtD
Doxepin—Decreased appetite—Donepezil—Alzheimer's disease	0.000125	0.000819	CcSEcCtD
Doxepin—Tachycardia—Rivastigmine—Alzheimer's disease	0.000125	0.000817	CcSEcCtD
Doxepin—Anorexia—Memantine—Alzheimer's disease	0.000124	0.000815	CcSEcCtD
Doxepin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000124	0.000813	CcSEcCtD
Doxepin—HTR2A—cerebellum—Alzheimer's disease	0.000124	0.00221	CbGeAlD
Doxepin—Skin disorder—Rivastigmine—Alzheimer's disease	0.000124	0.000813	CcSEcCtD
Doxepin—Fatigue—Donepezil—Alzheimer's disease	0.000124	0.000812	CcSEcCtD
Doxepin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000124	0.000809	CcSEcCtD
Doxepin—Pain—Donepezil—Alzheimer's disease	0.000123	0.000806	CcSEcCtD
Doxepin—Constipation—Donepezil—Alzheimer's disease	0.000123	0.000806	CcSEcCtD
Doxepin—Dizziness—Galantamine—Alzheimer's disease	0.000123	0.000804	CcSEcCtD
Doxepin—CYP3A4—nervous system—Alzheimer's disease	0.000122	0.00218	CbGeAlD
Doxepin—Hypotension—Memantine—Alzheimer's disease	0.000122	0.000799	CcSEcCtD
Doxepin—Anorexia—Rivastigmine—Alzheimer's disease	0.000122	0.000798	CcSEcCtD
Doxepin—HRH1—brain—Alzheimer's disease	0.000121	0.00215	CbGeAlD
Doxepin—CYP2D6—nervous system—Alzheimer's disease	0.00012	0.00214	CbGeAlD
Doxepin—Hypotension—Rivastigmine—Alzheimer's disease	0.000119	0.000782	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000119	0.000779	CcSEcCtD
Doxepin—ADRA2A—brain—Alzheimer's disease	0.000119	0.00211	CbGeAlD
Doxepin—Feeling abnormal—Donepezil—Alzheimer's disease	0.000119	0.000776	CcSEcCtD
Doxepin—Insomnia—Memantine—Alzheimer's disease	0.000118	0.000774	CcSEcCtD
Doxepin—Vomiting—Galantamine—Alzheimer's disease	0.000118	0.000773	CcSEcCtD
Doxepin—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000118	0.00077	CcSEcCtD
Doxepin—CYP3A4—central nervous system—Alzheimer's disease	0.000118	0.0021	CbGeAlD
Doxepin—Paraesthesia—Memantine—Alzheimer's disease	0.000117	0.000768	CcSEcCtD
Doxepin—Rash—Galantamine—Alzheimer's disease	0.000117	0.000766	CcSEcCtD
Doxepin—Dermatitis—Galantamine—Alzheimer's disease	0.000117	0.000766	CcSEcCtD
Doxepin—Dyspnoea—Memantine—Alzheimer's disease	0.000116	0.000763	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000116	0.000762	CcSEcCtD
Doxepin—Headache—Galantamine—Alzheimer's disease	0.000116	0.000761	CcSEcCtD
Doxepin—Somnolence—Memantine—Alzheimer's disease	0.000116	0.00076	CcSEcCtD
Doxepin—CYP2D6—central nervous system—Alzheimer's disease	0.000116	0.00206	CbGeAlD
Doxepin—Insomnia—Rivastigmine—Alzheimer's disease	0.000116	0.000757	CcSEcCtD
Doxepin—Dyspepsia—Memantine—Alzheimer's disease	0.000115	0.000753	CcSEcCtD
Doxepin—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000115	0.000751	CcSEcCtD
Doxepin—Urticaria—Donepezil—Alzheimer's disease	0.000114	0.000748	CcSEcCtD
Doxepin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000114	0.000746	CcSEcCtD
Doxepin—Body temperature increased—Donepezil—Alzheimer's disease	0.000114	0.000745	CcSEcCtD
Doxepin—Abdominal pain—Donepezil—Alzheimer's disease	0.000114	0.000745	CcSEcCtD
Doxepin—Somnolence—Rivastigmine—Alzheimer's disease	0.000114	0.000744	CcSEcCtD
Doxepin—Decreased appetite—Memantine—Alzheimer's disease	0.000114	0.000743	CcSEcCtD
Doxepin—CYP2D6—cerebellum—Alzheimer's disease	0.000113	0.00202	CbGeAlD
Doxepin—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000113	0.000738	CcSEcCtD
Doxepin—Fatigue—Memantine—Alzheimer's disease	0.000113	0.000737	CcSEcCtD
Doxepin—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000112	0.000737	CcSEcCtD
Doxepin—Constipation—Memantine—Alzheimer's disease	0.000112	0.000731	CcSEcCtD
Doxepin—Pain—Memantine—Alzheimer's disease	0.000112	0.000731	CcSEcCtD
Doxepin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000111	0.000727	CcSEcCtD
Doxepin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00011	0.000722	CcSEcCtD
Doxepin—Nausea—Galantamine—Alzheimer's disease	0.00011	0.000722	CcSEcCtD
Doxepin—Fatigue—Rivastigmine—Alzheimer's disease	0.00011	0.000721	CcSEcCtD
Doxepin—Imipramine—HTR6—Alzheimer's disease	0.00011	0.0285	CrCbGaD
Doxepin—Amitriptyline—HTR6—Alzheimer's disease	0.000109	0.0283	CrCbGaD
Doxepin—Constipation—Rivastigmine—Alzheimer's disease	0.000109	0.000716	CcSEcCtD
Doxepin—Pain—Rivastigmine—Alzheimer's disease	0.000109	0.000716	CcSEcCtD
Doxepin—Feeling abnormal—Memantine—Alzheimer's disease	0.000108	0.000705	CcSEcCtD
Doxepin—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000107	0.000699	CcSEcCtD
Doxepin—Hypersensitivity—Donepezil—Alzheimer's disease	0.000106	0.000694	CcSEcCtD
Doxepin—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000105	0.000689	CcSEcCtD
Doxepin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000104	0.000684	CcSEcCtD
Doxepin—Urticaria—Memantine—Alzheimer's disease	0.000104	0.000679	CcSEcCtD
Doxepin—Abdominal pain—Memantine—Alzheimer's disease	0.000103	0.000676	CcSEcCtD
Doxepin—Body temperature increased—Memantine—Alzheimer's disease	0.000103	0.000676	CcSEcCtD
Doxepin—Asthenia—Donepezil—Alzheimer's disease	0.000103	0.000676	CcSEcCtD
Doxepin—Pruritus—Donepezil—Alzheimer's disease	0.000102	0.000666	CcSEcCtD
Doxepin—Urticaria—Rivastigmine—Alzheimer's disease	0.000102	0.000665	CcSEcCtD
Doxepin—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000101	0.000661	CcSEcCtD
Doxepin—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000101	0.000661	CcSEcCtD
Doxepin—HTR2A—brain—Alzheimer's disease	0.000101	0.0018	CbGeAlD
Doxepin—Tripelennamine—CYP2D6—Alzheimer's disease	9.94e-05	0.0258	CrCbGaD
Doxepin—Diarrhoea—Donepezil—Alzheimer's disease	9.84e-05	0.000645	CcSEcCtD
Doxepin—Hypersensitivity—Memantine—Alzheimer's disease	9.62e-05	0.00063	CcSEcCtD
Doxepin—Dizziness—Donepezil—Alzheimer's disease	9.51e-05	0.000623	CcSEcCtD
Doxepin—Hypersensitivity—Rivastigmine—Alzheimer's disease	9.41e-05	0.000616	CcSEcCtD
Doxepin—Asthenia—Memantine—Alzheimer's disease	9.37e-05	0.000614	CcSEcCtD
Doxepin—Pruritus—Memantine—Alzheimer's disease	9.24e-05	0.000605	CcSEcCtD
Doxepin—CYP2D6—brain—Alzheimer's disease	9.19e-05	0.00164	CbGeAlD
Doxepin—Asthenia—Rivastigmine—Alzheimer's disease	9.17e-05	0.0006	CcSEcCtD
Doxepin—Vomiting—Donepezil—Alzheimer's disease	9.15e-05	0.000599	CcSEcCtD
Doxepin—Rash—Donepezil—Alzheimer's disease	9.07e-05	0.000594	CcSEcCtD
Doxepin—Dermatitis—Donepezil—Alzheimer's disease	9.06e-05	0.000593	CcSEcCtD
Doxepin—Pruritus—Rivastigmine—Alzheimer's disease	9.04e-05	0.000592	CcSEcCtD
Doxepin—Cyclobenzaprine—HTR2A—Alzheimer's disease	9.04e-05	0.0234	CrCbGaD
Doxepin—Headache—Donepezil—Alzheimer's disease	9.01e-05	0.00059	CcSEcCtD
Doxepin—Diarrhoea—Memantine—Alzheimer's disease	8.94e-05	0.000585	CcSEcCtD
Doxepin—Diarrhoea—Rivastigmine—Alzheimer's disease	8.74e-05	0.000572	CcSEcCtD
Doxepin—ABCB1—nervous system—Alzheimer's disease	8.65e-05	0.00154	CbGeAlD
Doxepin—Dizziness—Memantine—Alzheimer's disease	8.64e-05	0.000566	CcSEcCtD
Doxepin—Nausea—Donepezil—Alzheimer's disease	8.54e-05	0.00056	CcSEcCtD
Doxepin—Dizziness—Rivastigmine—Alzheimer's disease	8.45e-05	0.000553	CcSEcCtD
Doxepin—ABCB1—central nervous system—Alzheimer's disease	8.33e-05	0.00148	CbGeAlD
Doxepin—Vomiting—Memantine—Alzheimer's disease	8.3e-05	0.000544	CcSEcCtD
Doxepin—Cyclobenzaprine—CYP2D6—Alzheimer's disease	8.26e-05	0.0214	CrCbGaD
Doxepin—Rash—Memantine—Alzheimer's disease	8.23e-05	0.000539	CcSEcCtD
Doxepin—Dermatitis—Memantine—Alzheimer's disease	8.23e-05	0.000539	CcSEcCtD
Doxepin—Headache—Memantine—Alzheimer's disease	8.18e-05	0.000536	CcSEcCtD
Doxepin—ABCB1—cerebellum—Alzheimer's disease	8.14e-05	0.00145	CbGeAlD
Doxepin—Vomiting—Rivastigmine—Alzheimer's disease	8.12e-05	0.000532	CcSEcCtD
Doxepin—Rash—Rivastigmine—Alzheimer's disease	8.06e-05	0.000528	CcSEcCtD
Doxepin—Dermatitis—Rivastigmine—Alzheimer's disease	8.05e-05	0.000527	CcSEcCtD
Doxepin—Headache—Rivastigmine—Alzheimer's disease	8e-05	0.000524	CcSEcCtD
Doxepin—Nausea—Memantine—Alzheimer's disease	7.76e-05	0.000508	CcSEcCtD
Doxepin—Nausea—Rivastigmine—Alzheimer's disease	7.59e-05	0.000497	CcSEcCtD
Doxepin—ABCB1—brain—Alzheimer's disease	6.61e-05	0.00118	CbGeAlD
Doxepin—Nortriptyline—PTGS1—Alzheimer's disease	6.23e-05	0.0161	CrCbGaD
Doxepin—Clomipramine—SLC6A4—Alzheimer's disease	6.18e-05	0.016	CrCbGaD
Doxepin—Nortriptyline—SLC6A4—Alzheimer's disease	6.04e-05	0.0156	CrCbGaD
Doxepin—Thiothixene—HTR2A—Alzheimer's disease	6.01e-05	0.0156	CrCbGaD
Doxepin—Diphenhydramine—PTGS1—Alzheimer's disease	5.76e-05	0.0149	CrCbGaD
Doxepin—Trimipramine—SLC6A4—Alzheimer's disease	5.68e-05	0.0147	CrCbGaD
Doxepin—Thiothixene—CYP2D6—Alzheimer's disease	5.49e-05	0.0142	CrCbGaD
Doxepin—Desipramine—SLC6A4—Alzheimer's disease	4.97e-05	0.0129	CrCbGaD
Doxepin—Clomipramine—HTR2A—Alzheimer's disease	4.75e-05	0.0123	CrCbGaD
Doxepin—Chlorprothixene—HTR2A—Alzheimer's disease	4.73e-05	0.0122	CrCbGaD
Doxepin—Nortriptyline—HTR2A—Alzheimer's disease	4.64e-05	0.012	CrCbGaD
Doxepin—Trimipramine—HTR2A—Alzheimer's disease	4.37e-05	0.0113	CrCbGaD
Doxepin—Clomipramine—CYP2D6—Alzheimer's disease	4.34e-05	0.0112	CrCbGaD
Doxepin—Nortriptyline—CYP2D6—Alzheimer's disease	4.24e-05	0.011	CrCbGaD
Doxepin—Imipramine—SLC6A4—Alzheimer's disease	4.22e-05	0.0109	CrCbGaD
Doxepin—Promethazine—HTR2A—Alzheimer's disease	4.21e-05	0.0109	CrCbGaD
Doxepin—Amitriptyline—SLC6A4—Alzheimer's disease	4.19e-05	0.0108	CrCbGaD
Doxepin—Trimipramine—CYP2D6—Alzheimer's disease	3.99e-05	0.0103	CrCbGaD
Doxepin—Diphenhydramine—CYP2D6—Alzheimer's disease	3.92e-05	0.0102	CrCbGaD
Doxepin—Promethazine—CYP2D6—Alzheimer's disease	3.85e-05	0.00996	CrCbGaD
Doxepin—Desipramine—HTR2A—Alzheimer's disease	3.82e-05	0.00989	CrCbGaD
Doxepin—Promazine—HTR2A—Alzheimer's disease	3.7e-05	0.00958	CrCbGaD
Doxepin—Desipramine—CYP2D6—Alzheimer's disease	3.49e-05	0.00905	CrCbGaD
Doxepin—Imipramine—HTR2A—Alzheimer's disease	3.24e-05	0.00839	CrCbGaD
Doxepin—Amitriptyline—HTR2A—Alzheimer's disease	3.22e-05	0.00834	CrCbGaD
Doxepin—Imipramine—CYP2D6—Alzheimer's disease	2.96e-05	0.00767	CrCbGaD
Doxepin—Amitriptyline—CYP2D6—Alzheimer's disease	2.94e-05	0.00762	CrCbGaD
Doxepin—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	2.15e-06	2.91e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	2.15e-06	2.91e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	2.14e-06	2.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.14e-06	2.91e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	2.14e-06	2.91e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.14e-06	2.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	2.14e-06	2.9e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	2.13e-06	2.89e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.12e-06	2.88e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.11e-06	2.87e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—Alzheimer's disease	2.11e-06	2.87e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	2.11e-06	2.86e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.1e-06	2.85e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.1e-06	2.85e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	2.07e-06	2.81e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.05e-06	2.78e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.05e-06	2.78e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.04e-06	2.76e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.03e-06	2.76e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.02e-06	2.74e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	2.02e-06	2.74e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	2.01e-06	2.73e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	2.01e-06	2.73e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.01e-06	2.73e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—Alzheimer's disease	2e-06	2.72e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2e-06	2.72e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	2e-06	2.72e-05	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2e-06	2.72e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.99e-06	2.7e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.98e-06	2.69e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.98e-06	2.69e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.98e-06	2.69e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.98e-06	2.69e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.98e-06	2.69e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—Alzheimer's disease	1.98e-06	2.69e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.97e-06	2.67e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.96e-06	2.66e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.96e-06	2.66e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—Alzheimer's disease	1.95e-06	2.65e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.95e-06	2.65e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.95e-06	2.64e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.94e-06	2.64e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.94e-06	2.63e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.94e-06	2.63e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.94e-06	2.63e-05	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.93e-06	2.62e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.93e-06	2.62e-05	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.92e-06	2.61e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.91e-06	2.6e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.91e-06	2.6e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.91e-06	2.59e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.9e-06	2.58e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.9e-06	2.58e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.9e-06	2.58e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.89e-06	2.57e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.89e-06	2.56e-05	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.87e-06	2.54e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-06	2.53e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.86e-06	2.53e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.85e-06	2.51e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.85e-06	2.51e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.84e-06	2.5e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.84e-06	2.5e-05	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.84e-06	2.5e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.84e-06	2.49e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.83e-06	2.49e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.83e-06	2.49e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.83e-06	2.48e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.83e-06	2.48e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—AKT1—Alzheimer's disease	1.82e-06	2.48e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.82e-06	2.47e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.82e-06	2.47e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.82e-06	2.47e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.82e-06	2.47e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.81e-06	2.46e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.81e-06	2.46e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.77e-06	2.4e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.76e-06	2.39e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.75e-06	2.38e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.75e-06	2.37e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.74e-06	2.37e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.74e-06	2.37e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—Alzheimer's disease	1.71e-06	2.32e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-06	2.32e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.7e-06	2.31e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.7e-06	2.31e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.7e-06	2.3e-05	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.7e-06	2.3e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.68e-06	2.28e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	2.28e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.68e-06	2.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.67e-06	2.27e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—Alzheimer's disease	1.67e-06	2.27e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.67e-06	2.27e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.67e-06	2.27e-05	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.67e-06	2.26e-05	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.66e-06	2.26e-05	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.66e-06	2.25e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.66e-06	2.25e-05	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.65e-06	2.25e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.65e-06	2.24e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.65e-06	2.24e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.64e-06	2.23e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.64e-06	2.23e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.64e-06	2.22e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.64e-06	2.22e-05	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.64e-06	2.22e-05	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.63e-06	2.22e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.63e-06	2.22e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.63e-06	2.21e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.62e-06	2.2e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.62e-06	2.2e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.62e-06	2.2e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.62e-06	2.19e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.61e-06	2.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.61e-06	2.18e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.6e-06	2.18e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.59e-06	2.16e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.58e-06	2.14e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—Alzheimer's disease	1.57e-06	2.14e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.57e-06	2.13e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.57e-06	2.13e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.57e-06	2.13e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.56e-06	2.12e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.56e-06	2.12e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—Alzheimer's disease	1.56e-06	2.12e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.55e-06	2.1e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	2.1e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.54e-06	2.1e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.54e-06	2.1e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.54e-06	2.09e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.52e-06	2.06e-05	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.52e-06	2.06e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.52e-06	2.06e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.52e-06	2.06e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.51e-06	2.06e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.51e-06	2.05e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.51e-06	2.05e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.51e-06	2.05e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.51e-06	2.05e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.51e-06	2.04e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.5e-06	2.04e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.5e-06	2.04e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.5e-06	2.04e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.5e-06	2.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.49e-06	2.03e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.49e-06	2.02e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.49e-06	2.02e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.49e-06	2.02e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.49e-06	2.02e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.48e-06	2.01e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.48e-06	2.01e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.46e-06	1.99e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.44e-06	1.96e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.44e-06	1.95e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.43e-06	1.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.43e-06	1.94e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	1.93e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.41e-06	1.91e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.4e-06	1.9e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.4e-06	1.9e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.4e-06	1.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.39e-06	1.89e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.39e-06	1.89e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.38e-06	1.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.38e-06	1.88e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.38e-06	1.87e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.38e-06	1.87e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.38e-06	1.87e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-06	1.86e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.37e-06	1.86e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.37e-06	1.86e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.37e-06	1.86e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.36e-06	1.85e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.34e-06	1.82e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—Alzheimer's disease	1.33e-06	1.81e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.32e-06	1.79e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	1.78e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.29e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	1.29e-06	1.75e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.29e-06	1.75e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.28e-06	1.74e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.28e-06	1.74e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	1.28e-06	1.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.28e-06	1.73e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.28e-06	1.73e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.27e-06	1.73e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.26e-06	1.72e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	1.72e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.26e-06	1.71e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	1.71e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.25e-06	1.7e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.23e-06	1.67e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.22e-06	1.66e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.21e-06	1.64e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.2e-06	1.64e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.2e-06	1.63e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.19e-06	1.62e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-06	1.61e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.19e-06	1.61e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.17e-06	1.59e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.17e-06	1.59e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	1.59e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.16e-06	1.58e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.12e-06	1.52e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.12e-06	1.52e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.09e-06	1.48e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.46e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.07e-06	1.46e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.07e-06	1.45e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	1.45e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.06e-06	1.44e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.06e-06	1.44e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.06e-06	1.44e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.05e-06	1.43e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.05e-06	1.43e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.05e-06	1.42e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	1.41e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	1.41e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-06	1.41e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.03e-06	1.4e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—Alzheimer's disease	1.03e-06	1.4e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1e-06	1.36e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	9.86e-07	1.34e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—Alzheimer's disease	9.86e-07	1.34e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—Alzheimer's disease	9.74e-07	1.32e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	9.7e-07	1.32e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—Alzheimer's disease	9.68e-07	1.31e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	9.65e-07	1.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	9.64e-07	1.31e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	9.62e-07	1.31e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	9.52e-07	1.29e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	9.5e-07	1.29e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	9.09e-07	1.23e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—Alzheimer's disease	9.02e-07	1.23e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	8.95e-07	1.21e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	8.93e-07	1.21e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	8.9e-07	1.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	8.87e-07	1.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	8.82e-07	1.2e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	8.79e-07	1.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	8.76e-07	1.19e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	8.25e-07	1.12e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	8.14e-07	1.11e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—Alzheimer's disease	6.9e-07	9.37e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—Alzheimer's disease	6.73e-07	9.14e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—Alzheimer's disease	6.34e-07	8.61e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—Alzheimer's disease	6.29e-07	8.54e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—Alzheimer's disease	5.37e-07	7.3e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—Alzheimer's disease	4.15e-07	5.63e-06	CbGpPWpGaD
